Very late stent thrombosis in late stent malapposition after sirolimus-eluting stent implantation

International Heart Journal

Volumn 48, Issue 5, 2007, Pages 591-596

  Zhang, Feng ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Coronary angioplasty; Drug eluting stents; Late stent malapposition; Sirolimus; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEART ENZYME; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY STENT; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART REINFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; LATE STENT MALAPPOSITION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MONOTHERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; Q WAVE; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; THORAX PAIN; THROMBOSIS; VASCULAR PATENCY;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY OCCLUSION; CORONARY THROMBOSIS; EQUIPMENT DESIGN; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SIROLIMUS; STENTS; TIME FACTORS;

EID: 36749100785     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.591     Document Type: Article

References (27)

1. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002; 106: 798-803.
2. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-94.
3. Zhang F, Ge J, Qian J, et al. Sirolimus-Eluting Stents in Real-World Patients With ST-Segment Elevation Acute Myocardial Infarction. Int Heart J 2007; 48: 303-11.
4. Ako J, Morino Y, Honda Y, et al Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 1002-5.
5. Mintz G, Weissman NJ, Dawkins K, et al. Frequency, predictors, and clinical outcomes of late-acquired incomplete stent apposition in patients treated with Taxus stents a volumetric intravascular ultrasound meta-analysis from the TAXUS IV, V, and VI trials (abstr). J Am Coll Cardiol 2006; 47: 26B.
6. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-9.
7. Jimenez-Quevedo P, Sabate M, Angiolillo DJ, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol 2006; 47:2172-9.
8. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 2003; 108: 2747-50.
9. Qian J, Zhang F, Wu H, Fan B, Ge L, Ge J. Comparison of Intravascular Ultrasonic Imaging with versus without Incomplete Stent Apposition at Follow-up after Drug-etuting Stent Implantation. Int J Cardiovasc Imaging 2007; Aug 17: Epub ahead of print.
10. Zhang F, Qian JY, Ge JB. Late stent malapposition and marked positive vessel remodeling after sirolimus-eluting coronary stent implantation. Chin Med J (Engl) 2006; 119: 349-50.
11. Zhang F, Qian JY, Ge JB. Rapid development of late stent malapposition and coronary aneurysm following implantation of a paclitaxel-eluting coronary stent. Chin Med J (Engl) 2007; 120: 614-6.
12. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
13. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-5.
14. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
15. Nasser M, Kapeliovich M, Markiewicz W. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv 2005; 65: 516-9.
16. Van der Hoevan BL, Pires NM, Warda HM, et al. Drug-eluting stents: Results, promises and probluns. Int J Cardiol 2005; 99:9-17. (Review)
17. Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH Jr. Late thrombosis following treatment of instent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 2005; 65: 520-4.
18. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-92.
19. Karvouni E, Korovesis S, Katritsis DG Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005;91:e45.
20. Sharifkazemi MB, Zamirian M, Aslani A. A Current Problem in Cardiology: Very Late Thrombosis after Implantation of Sirolimus Eluting Stent. Cardiology 2006; 108: 273-4.
21. Yang J, Wang N, Zhang X, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-13.
22. Henderson D, Gunalingam B. Very late [corrected] thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2006; 68: 406-8.
23. Katayama T, Yamamoto T, Iwasaki Y; Yano K. Two Cases of Very Late Stent Thrombosis After Implantation of a Sirolimus-Eluting Stent Presenting as AMI. Int Heart J 2007; 48: 393-7.
24. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trists. Am J Med 2006; 119: 1056-61.
25. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting struts. Circulation 2006; 113: 1108-13.
26. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004; 44:1373-85. (Review)
27. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in human: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.